Investigational agents in myeloid disorders.
Ravandi
Farhad
F
Department of Leukemia, The University of Texas M. D. Anderson Cancer Center, Houston, Texas 77030, USA.
Cortes
Jorge
J
D000911:Antibodies, Monoclonal / Q000627:therapeutic use; D000970:Antineoplastic Agents / Q000737:chemistry / Q000145:classification* / Q000627:therapeutic use*; D018432:Drug Resistance, Multiple; D004791:Enzyme Inhibitors / Q000627:therapeutic use; D006402:Hematologic Diseases / Q000188:drug therapy* / Q000201:enzymology; D006801:Humans; D015398:Signal Transduction / Q000187:drug effects
D000911:Antibodies, Monoclonal; D000970:Antineoplastic Agents; D004791:Enzyme Inhibitors